Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001069530-20-000024
Filing Date
2020-04-09
Accepted
2020-04-09 16:13:13
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A sava-20200409xs3a.htm S-3/A 1149626
2 EX-5.1 sava-20200409xex5_1.htm EX-5.1 65185
3 EX-23.1 sava-20200409xex23_1.htm EX-23.1 3668
4 GRAPHIC sava-20200409xex5_1g001.jpg GRAPHIC 23914
5 GRAPHIC sava-20200409xs3ag001.jpg GRAPHIC 23611
6 GRAPHIC sava-20200409xs3ag002.jpg GRAPHIC 13151
7 GRAPHIC sava-20200409xs3ag003.jpg GRAPHIC 15808
  Complete submission text file 0001069530-20-000024.txt   1325529
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-237452 | Film No.: 20784673
SIC: 2834 Pharmaceutical Preparations